Novelion Therapeutics Inc 's ability to collect accounts receivable sequentially worsen to 5.65, pointing to a challenging and on top of that deteriorating business climate for the Major Pharmaceutical Preparations industry. Novelion Therapeutics Inc 's Accounts Receivable average collection period in the Mar 31 2019 quarter, has increased to 65 days, from 59 days, in the Dec 31 2018 quarter.

If we take a look into Healthcare sector 330 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Mar 31 2019 from 2478 to 2661.

What is Receivable Turnover Ratio?
What is Novelion Therapeutics Inc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

NVLN Receivables Turnover Ratio	(Mar 31 2019) I. Quarter	(Dec 31 2018) IV. Quarter	(Sep 30 2018) III. Quarter	(Jun 30 2018) II. Quarter	(Mar 31 2018) I. Quarter
Y / Y Receivable Change	67.29 %	30.29 %	48.53 %	36.58 %	40.44 %
Y / Y Revenue Change	17.16 %	4.63 %	5.81 %	-21.95 %	-8.34 %
Receivable Turnover Ratio (TTM)	5.65	6.15	6.58	7.14	8.21
NVLN's Total Ranking	# 2661	# 2478	# 2165	# 2652	# 2381
Accounts Receivable average collection period days	65	59	55	51	44
Seq. Receivable Change	-7.05 %	34.1 %	17.41 %	14.3 %	-27.61 %
Seq. Revenue Change	-20.9 %	34.21 %	-4.92 %	16.08 %	-29.36 %

Receivable Turnover Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 121
Healthcare Sector	# 331
Overall Market	# 2661

Receivable Turnover Ratio Statistics
High	Average	Low
8.99	7.12	5.65
(Dec 31 2017)		(Mar 31 2019)

NVLN Company Profile • Back to NVLN Efficiency Comparisons • Compare NVLN Receivables Turnover Ratio to its Competitors

Financial Statements
Novelion Therapeutics Inc 's Accounts Receivable	$ 27 Millions	Visit NVLN's Balance sheet
Novelion Therapeutics Inc 's Sales TTM	$ 135 Millions	Visit NVLN's Income Statement
Sources of NVLN's Revenues		Visit NVLN's Sales by Geography

Other Accounts Receivable Turnover Ratios
Major Pharmaceutical Preparations Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
NVLN's Receivable Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
NVLN's Growth Rates	NVLN's Roa	NVLN's Inventory Turnover Ratio	NVLN's Dividend Comparisons
NVLN's Profitability Ratios	NVLN's Roi	NVLN's Asset Turnover Ratio	NVLN's Dividend Growth
NVLN's Valuation Ratios	NVLN's Roe	NVLN's Financial Strength Ratios	NVLN's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Mar 31 2019, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Mar 31 2019	Receivable at quarter ending Mar 31 2019
Neuronetics Inc	13.76	$ 55.352 Millions	$ 4.023 Millions
Ibio inc	13.62	$ 1.314 Millions	$ 0.097 Millions
Syneos Health Inc	13.30	$ 4,451.926 Millions	$ 334.774 Millions
Travere Therapeutics Inc	12.92	$ 165.384 Millions	$ 12.797 Millions
Organogenesis Holdings Inc	12.92	$ 215.043 Millions	$ 16.647 Millions
Lifeloc Technologies Inc	12.74	$ 8.305 Millions	$ 0.652 Millions
Portola Pharmaceuticals inc	12.62	$ 55.655 Millions	$ 4.409 Millions
Musclepharm Corporation	12.52	$ 82.701 Millions	$ 6.606 Millions
Mannkind Corporation	12.51	$ 41.841 Millions	$ 3.344 Millions
Silk Road Medical Inc	12.47	$ 12.766 Millions	$ 1.024 Millions
Dmk Pharmaceuticals Corporation	12.36	$ 16.813 Millions	$ 1.360 Millions
Immucell Corporation	12.35	$ 12.516 Millions	$ 1.014 Millions
Corcept Therapeutics Inc	12.18	$ 258.417 Millions	$ 21.218 Millions
Scienture Holdings Inc	12.08	$ 4.491 Millions	$ 0.372 Millions
Edesa Biotech Inc	12.05	$ 0.298 Millions	$ 0.025 Millions
Inovio Pharmaceuticals Inc	11.94	$ 31.782 Millions	$ 2.661 Millions
Neurometrix Inc	11.93	$ 14.270 Millions	$ 1.196 Millions
Novaccess Global Inc	11.85	$ 1.397 Millions	$ 0.118 Millions
Cytomx Therapeutics Inc	11.81	$ 74.803 Millions	$ 6.334 Millions
Integrated Biopharma Inc	11.76	$ 48.958 Millions	$ 4.163 Millions
Exact Sciences Corporation	11.72	$ 526.209 Millions	$ 44.902 Millions
Zynex inc	11.71	$ 34.237 Millions	$ 2.925 Millions
Rafael Holdings Inc	11.68	$ 4.744 Millions	$ 0.406 Millions
Nuo Therapeutics Inc	11.56	$ 1.250 Millions	$ 0.108 Millions
Mimedx Group Inc	10.98	$ 341.517 Millions	$ 31.095 Millions
Durect Corp	10.90	$ 19.207 Millions	$ 1.762 Millions
Journey Medical Corp	10.89	$ 44.492 Millions	$ 4.086 Millions
Procyon Corporation	10.82	$ 4.140 Millions	$ 0.383 Millions
Wearable Health Solutions, Inc.	10.79	$ 0.878 Millions	$ 0.081 Millions
National Healthcare Corp	10.73	$ 985.673 Millions	$ 91.847 Millions

Date modified: 2026-09-08T15:09:34+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.